SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001725160-23-000018
Filing Date
2023-02-01
Accepted
2023-02-01 19:08:10
Documents
1
Period of Report
2023-02-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167529647568841.html 4  
1 FORM 4 wf-form4_167529647568841.xml 4 5609
  Complete submission text file 0001725160-23-000018.txt   7168
Mailing Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018
Business Address 1359 BROADWAY, SUITE 1710 NEW YORK NY 10018 (212) 433-3791
Zentalis Pharmaceuticals, Inc. (Issuer) CIK: 0001725160 (see all company filings)

IRS No.: 823607803 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZENTALIS PHARMACEUTICALS, LLC 530 SEVENTH AVENUE, SUITE 2201 NEW YORK NY 10018
Business Address
Blackwell Kimberly (Reporting) CIK: 0001816465 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39263 | Film No.: 23578303